Left atrial appendage closure: A new technique for clinical practice

Heart Rhythm

Volumn 11, Issue 3, 2014, Pages 514-521

  John Camm, A ^a   Colombo, Antonio ^b   Corbucci, Giorgio ^c   Padeletti, Luigi ^d  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c Boston Scientific   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Atrial fibrillation; Left atrial appendage; Left atrial appendage closure; Stroke risk; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; POLYESTER; POLYETHYLENE TEREPHTHALATE; WARFARIN;

AMPLATZER VASCULAR PLUG; AMPUTATION; ANTICOAGULATION; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ISCHEMIA; CARDIOVASCULAR CATHETER; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEATH; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART RIGHT LEFT SHUNT; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; LEFT ATRIAL APPENDAGE OCCLUSION; PATENT FORAMEN OVALE; PATHOGENESIS; PERCUTANEOUS DRAINAGE; PERICARDIAL EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SURGICAL APPROACH; SURGICAL TECHNIQUE; THERAPY EFFECT; THROMBUS; TRANSCATHETER APPROACH; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; UNITED STATES;

ATRIAL FIBRILLATION; LEFT ATRIAL APPENDAGE; LEFT ATRIAL APPENDAGE CLOSURE; STROKE RISK; THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; HUMANS; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STROKE;

EID: 84894534831     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.11.030     Document Type: Review

References (36)

1. R. Beinart, E.K. Heist, and M. Mansour et al. Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation J Cardiovasc Electrophysiol 22 2010 10 15
2. S.K. Thambidorai, R.D. Murray, and A.L. Klein et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study) Am J Cardiol 96 2005 935 941
3. L. Di Biase, P. Santangeli, and F. Gaita et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study J Am Coll Cardiol 60 2012 531 538
4. 2 scores Heart Rhythm 10 2013 921 925
5. SPAF Investigators Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation Ann Intern Med 128 1998 639 647
6. AF Investigators Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials Arch Intern Med 158 1998 1316 1320
7. T. Uemura, K. Kaikita, and H. Ogawa et al. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation Thromb Res 124 2009 28 32
8. H. Duygu, V. Barisik, and S. Kose et al. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation Europace 10 2008 210 214
9. S. Alberti, G. Angeloni, and C. Cerletti et al. Platelet-leukocyte mixed conjugates in patients with atrial fibrillation Platelets 20 2009 235 241
10. N.M. Al-Saady, O.A. Obel, and A.J. Camm Left atrial appendage: structure, function, and role in thromboembolism Heart 82 1999 547 555
11. M.C. Fang, A.S. Go, D.E. Singer for the ATRIA Study Group Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 2008 810 815
12. A.J. Camm, G.Y. Lip, and P. Kirchhof et al. 2012 Focused update of the ESC guidelines for the management of atrial fibrillation Eur Heart J 33 2012 2719 2747
13. V. Fuster, L.E. Rydén, and L.S. Wann et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 e101 e198
14. 2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation J Am Coll Cardiol 54 2009 2032 2039
15. R. Nieuwlaat, A. Capucci, and H.J. Crijns et al. on behalf of the European Heart Survey Investigators. Atrial fibrillation management: a prospective survey in ESC member countries. The Euro Heart Survey on Atrial Fibrillation Eur Heart J 26 2005 2422 2434
16. S.J. Connolly, M.D. Ezekowitz, and L. Wallentin et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
17. C.B. Granger, J.H. Alexander, and L. Wallentin et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
18. M.R. Patel, K.W. Mahaffey, and R.M. Califf et al. ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 889
19. R. Pisters, D.A. Lane, and G.Y. Lip et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey Chest 138 2010 1093 11100
20. Go A S, E.M. Hylek, and D.E. Singer et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study FREE JAMA 285 2001 2370 2375
21. J.A. Odell, J.L. Blackshear, and T.A. Orszulak et al. Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction? Ann Thorac Surg 61 1996 565 569
22. K. Bartus, F.T. Han, and RJ et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience J Am Coll Cardiol 62 2013 108 118
23. A. Massumi, M.G. Chelu, and A. Masekh et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation Am J Cardiol 111 2013 869 873
24. I. Cruz-Gonzalez, B.P. Yan, and Y.Y. Lam Left atrial appendage exclusion: state of the art Cathet Cardiovasc Interv 75 2010 806 813
25. L.P. Budge, K.M. Shaffer, and J.M. Mangrum et al. Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmental three dimensional cardiac CT J Interven Card Electrophysiol 23 2008 87 93
26. O.K. Mohrs, N. Wunderlich, and H.U. Kauczor et al. Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: a pilot study J Cardiovasc Magn Reson 13 2011 33
27. S.N. Hong, A. Rahimi, and T.D. O'Halloran et al. Cardiac magnetic resonance imaging and the WATCHMAN device J Am Coll Cardiol 55 2010 2785
28. Y. Wang, L. Di Biase, and A. Natale et al. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement J Cardiovasc Electrophysiol 21 2010 973 982
29. J.W. Park, A. Bethencour, and B. Leithäuser et al. Left atrial appendage closure with Amplatzer cardiac plug in AF: initial European experience Catheter Cardiovasc Interv 77 2011 700 706
30. AMPLATZER cardiac plug clinical trial. Available at: http:// clinicaltrials.gov/ct2/show/record/NCT01118299?term = LAA+ACP&rank = 3.
31. J. Park, H. Sievert, and H. Omran et al. TCT-112 interim data from Amplatzer Cardiac Plug Registry J Am Coll Cardiol 58 20 s1 2011 B33-B33
32. D.R. Holmes, V.Y. Reddy, P. Sick PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial Lancet 374 2009 534 542
33. V.Y. Reddy, D. Holmes, and S. Kar et al. Safety of percutaneous left atrial appendage closure: results from the WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry Circulation 123 2011 417 424
34. Holmes, DR. Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL). CIT. CNCC, Beijing, China. 20 March 2013. Interventional Innovation Summit Lecture.
35. V. Reddy, S. Doshi, and H. Sievert et al. Long term results of PROTECT-AF: the mortality effects of left atrial appendage closure versus warfarin for stroke prophylaxis in AF Heart Rhythm Society 2013 LBCT Scientific Sessions, May 9, 2013, Denver, Colorado
36. V.Y. Reddy, S. Möbius-Winkler, and H. Sievert et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology (ASAP Study) J Am Coll Cardiol 61 2013 2551 2556